TOPO Lab develops high-value ingredients from medicinal crops using plant tissue culture technology.
TOPO Lab develops functional food and pharmaceutical ingredients from medicinal crops using plant tissue culture. Its products include hemp-derived CBD, cosmetics and vaccine adjuvants, with a focus on producing high-value plant compounds. Based in Goyang-si, South Korea, the company was founded in 2021. In November 2024, it raised KRW 500 million in pre-series A funding led by CNT Tech, with participation from Nextdream Angelclub and Agricultural Policy Insurance & Finance Service.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in